Winter Zhang

931 total citations
8 papers, 246 citations indexed

About

Winter Zhang is a scholar working on Biotechnology, Molecular Biology and Immunology. According to data from OpenAlex, Winter Zhang has authored 8 papers receiving a total of 246 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Biotechnology, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Winter Zhang's work include Cancer Research and Treatments (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Immune cells in cancer (3 papers). Winter Zhang is often cited by papers focused on Cancer Research and Treatments (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Immune cells in cancer (3 papers). Winter Zhang collaborates with scholars based in United States, Thailand and China. Winter Zhang's co-authors include Francesco Parlati, Mirna L.M. Rodriguez, Ana Galan Cobo, Pan Tong, Pei-Hsuan Chen, John D. Minna, Xiao Qu, Alissa Poteete, Marlese A. Pisegna and Varsha Gandhi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Winter Zhang

8 papers receiving 244 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Winter Zhang United States	5	171	102	69	64	25	8	246
Brendah K. Masisi United Kingdom	9	229 1.3×	181 1.8×	69 1.0×	68 1.1×	24 1.0×	12	324
Elisa Pardella Italy	9	205 1.2×	130 1.3×	62 0.9×	34 0.5×	12 0.5×	15	323
Jaebon Lee South Korea	6	167 1.0×	160 1.6×	62 0.9×	78 1.2×	22 0.9×	8	301
Estelle Li Canada	6	195 1.1×	76 0.7×	78 1.1×	68 1.1×	28 1.1×	11	311
Michael D. Arensman United States	5	227 1.3×	115 1.1×	93 1.3×	68 1.1×	7 0.3×	8	332
Jianwei Liao China	8	213 1.2×	132 1.3×	98 1.4×	21 0.3×	20 0.8×	12	314
Katya Marjon United States	3	241 1.4×	58 0.6×	72 1.0×	23 0.4×	13 0.5×	5	302
Paul Allegakoen United States	4	203 1.2×	146 1.4×	128 1.9×	85 1.3×	10 0.4×	8	336
Peter J. Mullen Canada	3	228 1.3×	88 0.9×	37 0.5×	20 0.3×	12 0.5×	4	290
Sarah Neidler United Kingdom	3	200 1.2×	152 1.5×	59 0.9×	36 0.6×	29 1.2×	3	271

Countries citing papers authored by Winter Zhang

Since Specialization

Citations

This map shows the geographic impact of Winter Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Winter Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Winter Zhang more than expected).

Fields of papers citing papers by Winter Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Winter Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Winter Zhang. The network helps show where Winter Zhang may publish in the future.

Co-authorship network of co-authors of Winter Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Winter Zhang. A scholar is included among the top collaborators of Winter Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Winter Zhang. Winter Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

MacKinnon, Andrew L., Jason Chen, Tony Chieh‐Ting Huang, et al.. (2020). 705 Anti-tumor activity of CB-668, a potent, selective and orally bioavailable small-molecule inhibitor of the immuno-suppressive enzyme Interleukin 4 (IL-4)-Induced Gene 1 (IL4I1). SHILAP Revista de lepidopterología. A423.2–A424. 6 indexed citations

Cobo, Ana Galan, Piyada Sitthideatphaiboon, Xiao Qu, et al.. (2019). LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS -Mutant Lung Adenocarcinoma. Cancer Research. 79(13). 3251–3267. 215 indexed citations

Works, Melissa, Mark K. Bennett, Ethan Emberley, et al.. (2016). Abstract 552: Immuno-oncology agent CB-1158 is a potent and selective arginase inhibitor and causes an immune-mediated anti-tumor response. Cancer Research. 76(14_Supplement). 552–552. 10 indexed citations

Steggerda, Susanne, Mark K. Bennett, Jason Chen, et al.. (2016). Abstract B045: Arginase inhibitor CB-1158 elicits immune-mediated antitumor responses as a single agent and in combination with other immunotherapies. Cancer Immunology Research. 4(11_Supplement). B045–B045. 2 indexed citations

MacKinnon, Andrew L., Mark K. Bennett, Matt Gross, et al.. (2015). Metabolomic, Proteomic and Genomic Profiling Identifies Biomarakers of Sensitivity to Glutaminase Inhibitor CB-839 in Multiple Myeloma. Blood. 126(23). 1802–1802. 4 indexed citations

Gross, Matthew, Jason Chen, Ethan Emberley, et al.. (2015). Abstract A195: CB-1158 inhibits the immuno-oncology target arginase and causes an immune mediated anti-tumor response. Molecular Cancer Therapeutics. 14(12_Supplement_2). A195–A195. 4 indexed citations

Rodriguez, Mirna L.M., Winter Zhang, Mark K. Bennett, et al.. (2015). Abstract 4711: CB-839, a selective glutaminase inhibitor, synergizes with signal transduction pathway inhibitors to enhance anti-tumor activity. Cancer Research. 75(15_Supplement). 4711–4711. 4 indexed citations

Boroughs, Lindsey K., Pei-Hsuan Chen, Ling Cai, et al.. (2015). Abstract 4710: Evaluation of the glutaminase inhibitor CB-839 in non-small cell lung cancer. Cancer Research. 75(15_Supplement). 4710–4710. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact